Cite
HARVARD Citation
Saha, S. et al. (n.d.). Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment. European journal of cancer. pp. S37-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Saha, S. et al. (n.d.). Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment. European journal of cancer. pp. S37-. [Online].